Anti-inflammatory spiroditerpenoids from Penicillium bialowiezense
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Jaeyoung | - |
dc.contributor.author | Kim, Min Jee | - |
dc.contributor.author | Kim, Dong-Cheol | - |
dc.contributor.author | Kwon, Haeun | - |
dc.contributor.author | Ryu, Seung Mok | - |
dc.contributor.author | Shim, Sang Hee | - |
dc.contributor.author | Guo, Yuanqiang | - |
dc.contributor.author | Hong, Seung-Beom | - |
dc.contributor.author | Yim, Joung Han | - |
dc.contributor.author | Kim, Youn-Chul | - |
dc.contributor.author | Oh, Hyuncheol | - |
dc.contributor.author | Lee, Dongho | - |
dc.date.accessioned | 2021-11-16T19:41:01Z | - |
dc.date.available | 2021-11-16T19:41:01Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2021-08 | - |
dc.identifier.issn | 0045-2068 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/127671 | - |
dc.description.abstract | Inflammation is a vital process that maintains tissue homeostasis. However, it is widely known that uncontrolled inflammation can contribute to the development of various diseases. This study aimed to discover antiinflammatory metabolites from Penicillium bialowiezense. Seven spiroditerpenoids, including two new compounds, breviones P and Q (1 and 2), were isolated and characterized by various spectroscopic and spectrometric methods. All isolated compounds were initially tested for their inhibitory effects against lipopolysaccharideinduced nitric oxide (NO) production in RAW 264.7 macrophages. Of these, brevione A (3) exhibited this activity with a half-maximal inhibitory concentration value of 9.5 mu M. Further mechanistic studies demonstrated that 3 could suppress the expression of pro-inflammatory cytokines and mediators, such as NO, prostaglandin E2, interleukin (IL)-1 beta, tumor necrosis factor-alpha, IL-6, and IL-12 by inhibiting the activation of nuclear factor-kappa B and c-Jun N-terminal kinase. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | NF-KAPPA-B | - |
dc.subject | LPS-INDUCED INFLAMMATION | - |
dc.subject | BREVIANE SPIRODITERPENOIDS | - |
dc.subject | MECHANISMS | - |
dc.subject | PATHWAYS | - |
dc.title | Anti-inflammatory spiroditerpenoids from Penicillium bialowiezense | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Dongho | - |
dc.identifier.doi | 10.1016/j.bioorg.2021.105012 | - |
dc.identifier.scopusid | 2-s2.0-85107051480 | - |
dc.identifier.wosid | 000663790900006 | - |
dc.identifier.bibliographicCitation | BIOORGANIC CHEMISTRY, v.113 | - |
dc.relation.isPartOf | BIOORGANIC CHEMISTRY | - |
dc.citation.title | BIOORGANIC CHEMISTRY | - |
dc.citation.volume | 113 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | LPS-INDUCED INFLAMMATION | - |
dc.subject.keywordPlus | BREVIANE SPIRODITERPENOIDS | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | PATHWAYS | - |
dc.subject.keywordAuthor | Penicillium bialowiezense | - |
dc.subject.keywordAuthor | Spiroditerpenoid | - |
dc.subject.keywordAuthor | Brevione | - |
dc.subject.keywordAuthor | Anti-inflammatory effect | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.